Glycemic Control in Diabetic Hospitalized Patients

NCT04800861 | Completed DMC

• 1 other identifier: 1121
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

With the advanced management of diabetes and new innovative anti-hyperglycemic therapy hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the hospital in general wards. Efforts from health care providers to assess and control blood sugar by a simplified method such as certified point of care hand-sized glucometers is the fruitful protocol if the results near the target that is endorsed by well-known diabetes societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl after a meal. The unstable economy and political crises with the pandemic of Covid-19 making us use a glucometer to monitor and control the fluctuation of blood sugar in order to decrease the burden on the patients and health care providers in the form of a stay in the hospital and minimize wasting laboratory resources.

Conditions

Diabetes; Diabetes Mellitus

Keywords

diabetes mellitus; hyperglycemia; glycemic control; inpatient

Outcome Measures

Primary Outcomes (1)

• glycemic control

  percentage of patients with glucose measurement (Random Blood Sugar, RBS, Fasting Blood Sugar, FBS) between 140-180 measured with bedside glucometers preferably before meals and at 6 am for fasting blood sugars or as directed by the physician

  From hospital admission to hospital discharge for a median of 7 days and up to 1 month

Secondary Outcomes (2)

• average blood glucose value per ward

  From hospital admission to hospital discharge for a median of 7 days and up to 1 month

• average per patient

  From hospital admission to hospital discharge for a median of 7 days and up to 1 month

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

diabetic patients admitted in the hospital

You may qualify if:

• admitted to the hospital

You may not qualify if:

• none

Sponsors & Collaborators

• AlFayhaa General Hospital: lead

Study Sites (1)

AlFayhaa Teaching hospital

Basra, 99999, Iraq

Location

MeSH Terms

Conditions

Diabetes Mellitus; Hyperglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• AbdulSattar J Yousif, MD

  Al-Fayhaa teaching hospital

  STUDY CHAIR

• Ali Hussein A Alhamza, MD

  Al-Fayhaa teaching hospital

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 5, 2021
• First Posted: March 16, 2021
• Study Start: January 1, 2021
• Primary Completion: July 1, 2021
• Study Completion: July 1, 2021
• Last Updated: December 27, 2022

Record last verified: 2021-03

Locations

IR (1)